Literature DB >> 9057131

Myelination and remyelination of aggregate rat brain cell cultures enriched with macrophages.

A J Loughlin1, C A Copelman, A Hall, T Armer, B C Young, D N Landon, M L Cuzner.   

Abstract

We reported previously that accumulation of myelin basic protein (MBP) in foetal brain aggregate cultures is enhanced by supplementation with peritoneal macrophages. The present study demonstrates that the rate of MBP accumulation in macrophage-enriched cultures continues to increase over time unaccompanied by a matching increase in the oligodendrocyte marker cyclic nucleotide phosphodiesterase, while that of control cultures reaches a plateau. These observations are supported by electron microscopic evidence of cumulative numbers of myelinated axons in the aggregates over time and by enhanced expression of myelin protein genes in macrophage-enriched relative to control cultures. Aggregates demyelinate following short-term exposure to cytokines and antimyelin oligodendrocyte glycoprotein antibody, and MBP synthesis resumes following removal of demyelinating agents. Supplementation of cultures with macrophages influences the degree of myelin breakdown and remyelination, drawing attention to the role that macrophage-derived growth factors may play in myelinogenesis and myelin repair in inflammatory demyelinating disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9057131

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  12 in total

Review 1.  Macrophages in CNS remyelination: friend or foe?

Authors:  L T Diemel; C A Copelman; M L Cuzner
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

Review 2.  The pathogenesis of murine coronavirus infection of the central nervous system.

Authors:  Thomas E Lane; Martin P Hosking
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

3.  Interleukin-1beta promotes repair of the CNS.

Authors:  J L Mason; K Suzuki; D D Chaplin; G K Matsushima
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

4.  Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.

Authors:  Veronique E Miron; Samuel K Ludwin; Peter J Darlington; Andrew A Jarjour; Betty Soliven; Timothy E Kennedy; Jack P Antel
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

5.  Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus.

Authors:  M K Njenga; P D Murray; D McGavern; X Lin; K M Drescher; M Rodriguez
Journal:  J Neuropathol Exp Neurol       Date:  1999-01       Impact factor: 3.685

6.  Myelinated, synapsing cultures of murine spinal cord--validation as an in vitro model of the central nervous system.

Authors:  C E Thomson; M McCulloch; A Sorenson; S C Barnett; B V Seed; I R Griffiths; M McLaughlin
Journal:  Eur J Neurosci       Date:  2008-09-10       Impact factor: 3.386

Review 7.  Paving the axonal highway: from stem cells to myelin repair.

Authors:  Raniero L Peru; Nicole Mandrycky; Brahim Nait-Oumesmar; Q Richard Lu
Journal:  Stem Cell Rev       Date:  2008-12       Impact factor: 5.739

8.  Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum.

Authors:  Delphine Meffre; Ghjuvan'Ghjacumu Shackleford; Mehdi Hichor; Victor Gorgievski; Eleni T Tzavara; Amalia Trousson; Abdel M Ghoumari; Cyrille Deboux; Brahim Nait Oumesmar; Philippe Liere; Michael Schumacher; Etienne-Emile Baulieu; Frédéric Charbonnier; Julien Grenier; Charbel Massaad
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-28       Impact factor: 11.205

9.  Fingolimod modulates microglial activation to augment markers of remyelination.

Authors:  Samuel J Jackson; Gavin Giovannoni; David Baker
Journal:  J Neuroinflammation       Date:  2011-07-05       Impact factor: 8.322

10.  Neuropathology of vitamin B12 deficiency in the Cd320-/- mouse.

Authors:  Kaveri Arora; Jeffrey M Sequeira; Juan M Alarcon; Brandi Wasek; Erland Arning; Teodoro Bottiglieri; Edward V Quadros
Journal:  FASEB J       Date:  2018-10-10       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.